Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
WuXi AppTec
25 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Acquisition
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
PR-M11-20-040
Capacity Expansion
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory
PR-M11-20-019
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
PR-M05-20-NI-025
Expanded Capacity
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
PR-M01-20-NI-010
Collaboration
Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects
PR-M05-19-NI-073
M&A
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
PR-M05-19-NI-030
Healthcare
The First WuXi Healthcare Forum Opens in Shanghai
PR-M03-19-NI-019
Growth
WuXi AppTec Plans for Growth
PAO-M12-18-NI-005-10
Awards
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
PR-M12-18-NI-008
Announcement
WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance
PR-M10-18-NI-029
Artificial Intelligence
WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies
PR-M09-18-NI-054
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
PR-M06-18-NI-057
Artificial Intelligence
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
PR-M06-18-NI-037
Novel Medicine
WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients
PAO-M05-18-CL-004
IPO
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
PR-M05-18-NI-037
Expanded Capacity
WuXi STA to Build a New R&D Center in Shanghai
PR-M05-18-NI-001
Drug Candidate
STA Pharmaceutical Co. to Manufacture Phoenix Molecular Designs’ Anticancer Candidate
PAO-M04-18-NI-018
Expanded Capacity
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services
PR-M04-18-NI-75
Partnership
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies
PR-M03-18-NI-090
Genomics
WuXi NextCODE Unveils Genomics Partnership with Google Cloud
PR-M03-18-NI-036
DCAT
WuXi AppTec Laboratory Testing Division Becomes DCAT Member
PAO-M03-18-NI-002
Strategic Collaboration
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
PR-M02-18-NI-93
Launch
WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com
PR-M02-18-NI-039
Joint Venture
WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services
PR-M01-18-NI-027
1
2
»
.svg)
